止痛贴市场 - 全球产业规模、份额、趋势、机会和预测，按产品类型、类型、配销通路、地区和竞争细分，2020-2030F

2024 年全球止痛贴片市场价值为 51.2 亿美元，预计到 2030 年将达到 67.8 亿美元，预测期内复合年增长率为 4.76%。止痛贴已成为治疗各种疼痛的方便有效的解决方案，为传统口服药物提供了替代方案。这些贴片透过透皮药物传递系统提供局部缓解，使其成为寻求舒适和便利的疼痛管理患者的理想选择。近年来，受慢性疼痛病症患病率不断上升、人口老化以及对非侵入性疼痛管理解决方案的需求不断增长等因素推动，全球止痛贴市场经历了大幅增长。关节炎、背痛、神经性疼痛和纤维肌痛等慢性疼痛病症在全球呈上升趋势。止痛贴片提供了一种针对性的方法来控制慢性疼痛，并且没有口服药物的副作用，因此很受欢迎。随着全球人口老化，与年龄相关的疼痛状况的发生率也越来越高。老年人通常更喜欢止痛贴，因为它们易于使用且能持续缓解疼痛，无需频繁使用。止痛贴是非侵入性的，无需注射或服用药丸，是一种控制疼痛的谨慎方法。这对寻求替代疼痛缓解方法的患者很有吸引力。药物传递技术的持续研究和开发已带来更有效率和更持久的止痛贴片型。这些贴片现在可以输送多种药物，包括鸦片类药物、非类固醇抗发炎药 (NSAID) 和肌肉鬆弛剂。製药公司和医疗器材製造商正在不断扩大其止痛贴产品组合。这包括开发针对特定疼痛类型的贴片，以及引入创新功能，例如根据患者需求监测和调整药物传递的智慧贴片。

主要市场驱动因素

慢性疼痛盛行率上升推动全球止痛贴市场发展

主要市场挑战

定价和报销

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球止痛贴市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（非鸦片类贴片、鸦片类贴片）
  • 依类型（处方药、非处方药）
  • 按配销通路（医院药房、药局和零售药房、线上供应商）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美止痛贴市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲止痛贴市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区止痛贴市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲止痛贴市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲止痛贴市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• NEXGEL Inc.
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Endo, Inc.
• Purdue Pharma LP
• Amneal Pharmaceuticals LLC
• Grunenthal GmbH

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Pain Patch Market was valued at USD 5.12 Billion in 2024 and is expected to reach USD 6.78 Billion by 2030 with a CAGR of 4.76% during the forecast period. Pain patches have emerged as a convenient and effective solution for managing various forms of pain, offering an alternative to traditional oral medications. These patches deliver localized relief through transdermal drug delivery systems, making them an attractive option for individuals seeking comfort and convenience in pain management. The global pain patch market has experienced substantial growth in recent years, driven by factors such as the increasing prevalence of chronic pain conditions, an aging population, and a growing demand for non-invasive pain management solutions. Chronic pain conditions, such as arthritis, back pain, neuropathic pain, and fibromyalgia, are on the rise globally. Pain patches offer a targeted approach to manage chronic pain without the side effects associated with oral medications, contributing to their popularity. As the global population ages, there is a higher incidence of age-related pain conditions. Elderly individuals often prefer pain patches as they are easy to apply and provide sustained relief without the need for frequent dosing. Pain patches are non-invasive and offer a discreet way to manage pain without the need for injections or pills. This appeals to patients looking for alternative methods of pain relief. Ongoing research and development in drug delivery technologies have led to more efficient and long-lasting pain patch formulations. These patches can now deliver a variety of medications, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and muscle relaxants. Pharmaceutical companies and medical device manufacturers are continuously expanding their pain patch product portfolios. This includes the development of patches for specific pain types and the introduction of innovative features such as smart patches that monitor and adjust drug delivery based on the patient's needs.

Key Market Drivers

Rising Prevalence of Chronic Pain is Driving the Global Pain Patch Market

Chronic pain is a widespread and debilitating condition that affects millions of people worldwide, significantly impacting their quality of life. As the global population continues to age and the incidence of chronic conditions such as arthritis, back pain, and neuropathy rises, the demand for effective pain management solutions is on the rise. One such solution that is gaining traction in the healthcare industry is the pain patch. These transdermal patches are becoming increasingly popular due to their convenience, effectiveness, and ability to provide consistent pain relief. According to Centers for Disease Control and Prevention, in 2021, approximately 20.9% of U.S. adults, equating to 51.6 million people, reported experiencing chronic pain. Of these, 6.9% (17.1 million individuals) experienced high-impact chronic pain, which significantly restricts daily activities. The prevalence of chronic pain was notably higher among non-Hispanic American Indian or Alaska Native

Key Market Challenges

Pricing and Reimbursement

The pricing of pain patches is a major challenge in the healthcare market, particularly in regions where there is a strong emphasis on cost containment and budget restrictions within public and private healthcare systems. Manufacturers of pain patches must navigate complex pricing structures while attempting to keep their products affordable for a wide range of patients. Reimbursement policies from insurance companies significantly influence the accessibility of pain patches to patients. If insurance plans do not cover certain treatments or if the reimbursement rates are low, patients may be less likely to afford these products, thereby limiting market reach. Additionally, the negotiation process between manufacturers and insurers can affect the final pricing, potentially influencing the uptake of pain patches in both institutional and consumer markets. Therefore, manufacturers are tasked with balancing product quality and affordability, which requires ongoing adaptation to changing market dynamics and reimbursement structures.

Key Market Trends

Technological Advancements

The global healthcare industry is witnessing a significant transformation, driven by rapid technological advancements and a growing emphasis on patient-centric solutions. One notable area where these changes are manifesting is in the pain management sector. Traditional methods of pain relief, such as oral medications, injections, and physical therapy, are now being complemented and, in some cases, replaced by innovative solutions like pain patches. These patches are gaining traction in the global market due to their convenience, effectiveness, and advancements in their technology. In January 2021, Hisamitsu Pharmaceutical Co., Inc. declared that it had received approval for modifying certain aspects of the previously approved specifications for their new transdermal analgesic anti-inflammatory patches, known as "Mohrus Paps XR 120 mg and 240 mg." This adjustment aimed to alleviate the irritation caused by the current additives.

Key Market Players

• NEXGEL Inc.
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Endo, Inc.
• Purdue Pharma L.P.
• Amneal Pharmaceuticals LLC
• Grunenthal GmbH

Report Scope:

In this report, the Global Pain Patch Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pain Patch Market, By Product Type:

• Non-Opioid Patches
• Opioid Patches

Pain Patch Market, By Type:

• Prescription Medicines
• OTC Medicines

Pain Patch Market, By Distribution Channel:

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Providers

Pain Patch Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Pain Patch Market.

Available Customizations:

Global Pain Patch market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pain Patch Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Non-Opioid Patches, Opioid Patches)
  • 5.2.2. By Type (Prescription Medicines, OTC Medicines)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Pain Patch Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pain Patch Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Pain Patch Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Pain Patch Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Pain Patch Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pain Patch Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Pain Patch Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Italy Pain Patch Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. France Pain Patch Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Pain Patch Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Pain Patch Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pain Patch Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Pain Patch Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Pain Patch Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Pain Patch Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Pain Patch Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Pain Patch Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pain Patch Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Pain Patch Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Pain Patch Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Pain Patch Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pain Patch Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Pain Patch Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Pain Patch Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. NEXGEL Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Viatris Inc.
• 14.3. Johnson and Johnson
• 14.4. Teva Pharmaceutical Industries Ltd.
• 14.5. Sorrento Therapeutics Inc.
• 14.6. Hisamitsu Pharmaceutical Co., Inc.
• 14.7. Endo, Inc.
• 14.8. Purdue Pharma L.P.
• 14.9. Amneal Pharmaceuticals LLC
• 14.10. Grunenthal GmbH

15. Strategic Recommendations

16. About Us & Disclaimer